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Abstract
Galactic Cosmic Radiation consisting of high-energy, high-charged (HZE) particles poses a significant threat to future
astronauts in deep space. Aside from cancer, concerns have been raised about late degenerative risks, including effects on
the brain. In this study we examined the effects of
56Fe particle irradiation in an APP/PS1 mouse model of Alzheimer’s
disease (AD). We demonstrated 6 months after exposure to 10 and 100 cGy
56Fe radiation at 1 GeV/m, that APP/PS1 mice
show decreased cognitive abilities measured by contextual fear conditioning and novel object recognition tests.
Furthermore, in male mice we saw acceleration of Ab plaque pathology using Congo red and 6E10 staining, which was
further confirmed by ELISA measures of Ab isoforms. Increases were not due to higher levels of amyloid precursor protein
(APP) or increased cleavage as measured by levels of the b C-terminal fragment of APP. Additionally, we saw no change in
microglial activation levels judging by CD68 and Iba-1 immunoreactivities in and around Ab plaques or insulin degrading
enzyme, which has been shown to degrade Ab. However, immunohistochemical analysis of ICAM-1 showed evidence of
endothelial activation after 100 cGy irradiation in male mice, suggesting possible alterations in Ab trafficking through the
blood brain barrier as a possible cause of plaque increase. Overall, our results show for the first time that HZE particle
radiation can increase Ab plaque pathology in an APP/PS1 mouse model of AD.
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Introduction
After more than 50 years of manned space exploration, plans
are underway to return to the moon and explore other locations
beyond Earth’s protective magnetic field, including asteroids and
Mars. This does not come without significant risk. In particular,
a major risk factor for human health in deep space is radiation.
The galactic environment is dominated by high levels of protons
arising from solar flares, and low, but continuous levels of Galactic
Cosmic Radiation (GCR) [1]. GCR is made of high-energy, high-
charged (HZE) particles that contain a variety of different
elements, including
56Fe particles [2]. Radiation-induced late
degenerative changes represent a potential risk for future
astronauts [1,3]. A significant focus of NASA’s efforts to assess
radiation risk has centered on possible late effects in the central
nervous system (CNS). For example, similar to more well studied
terrestrial radiation such as c rays [4],
56Fe particle radiation has
been documented to cause neuroinflammation [5], a clear in-
dicator of CNS damage [6]. Furthermore, even at very low doses,
56Fe particle radiation can result in neurogenesis defects and
cognitive impairment [5,7]. Given that there is a high probability
of HZE particles hitting CNS neurons during a space mission [2],
concerns have been raised regarding the potential effects of space
radiation on promoting neurodegenerative disorders, including
Alzheimer’s disease (AD), which will afflict as many as 45% of
individuals who survive past the age of 85 [8].
AD is characterized by a progressive cognitive decline over
several years [9]. This cognitive decline is thought in part, to result
from an ongoing chronic neuroinflammatory process [10]. One of
the key players in neuroinflammation and one of the two major
histopathological hallmarks of the disease is accumulation of
amyloid beta (Ab) into extracellular, dense fibril plaques [11].
Monitoring plaque progression in vivo has been used to gauge
disease severity [12] and has recently been approved as a di-
agnostic tool for human imaging studies [13]. Since the in-
flammatory environment appears to play a role in driving disease
progression [11], any inflammatory changes can alter AD
pathology. We, as well as other groups, have shown that exposure
of the CNS to various cytokines [14–16] or bacterial components
[17] can drastically alter plaque pathology depending on the
specific stimulus provided. Additionally, there is accumulating
evidence that peripheral inflammatory stimuli can also influence
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dynamic and sensitive to CNS environmental changes. Inflam-
mation is also associated with neurovascular dysfunction. Further-
more, this dysfunction has been linked to impaired transport of Ab
out of the brain, resulting in increased accumulation and disease
progression [20]. Indeed, decreased blood brain barrier (BBB)
transport of Ab has been implicated in mouse and human studies
[21]. Interestingly, radiation has also been clearly documented to
cause BBB break down and dysfunction [22].
The potential disease-altering effects of GCR prompted us to
examine if HZE radiation influences AD pathological progression
using an APP/PS1 mouse model that shows age-associated
accumulation of Ab plaques and cognitive dysfunction [23,24].
We discovered that
56Fe particle radiation resulted in cognitive
impairment and increased Ab plaque pathology at cumulative
doses similar to those that astronauts might be exposed to on
exploratory missions to deep space and Mars [3].
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. Animal
protocols were reviewed and approved by the University of
Rochester (Protocol Number: 2008–38) and Brookhaven National
Laboratory’s (BNL) (Protocol Number: 442) Institutional Animal
Care and Use Committees.
Animals
Twenty-nine male and twenty female APPswe/PSEN1dE9
(APP/PS1) mice (stock no. 004462) on a mixed C3H/HeJ and
C57BL/6 background were purchased from The Jackson Labo-
ratory at approximately 3 months of age. Animals were shipped to
BNL and allowed to acclimate. Mice were housed five per cage in
temperature (23 6 3uC) and light (12:12 light:dark) controlled
rooms with free access to chow and water. After radiation
exposure at 3.5 months of age, animals were shipped back to the
University of Rochester until euthanasia. Mice were routinely
monitored for health issues and had no observable problems at the
time of euthanasia. Male mice were euthanized at 9.5 months of
age while female mice were euthanized at 7 months due to
concerns raised regarding early death.
Irradiation
Radiation exposures were performed at NASA’s Space Radi-
ation Laboratory at BNL. Animals were loaded into ventilated
50 mL polystyrene conical tubes and irradiated, 8 at a time, using
a foam tube holder positioned at the center of a 20620 cm beam
of iron ions accelerated to 1 GeV/m at a dose rate ranging from
0.1–1 Gy/min. Male mice received total doses of either 10 cGy or
100 cGy. Female mice received only a 100 cGy dose. Control
mice were similarly placed in tubes and sham irradiated.
Behavioral Testing
Memory was tested using two different paradigms. The first was
contextual fear conditioning, which tests the ability of the subject
to recognize an environment associated with an adverse stimulus
(foot shock). Fear conditioning was set up, performed, and
analyzed as previously described [25]. In brief, mice were allowed
to explore a novel chamber for 3 minutes, then 15 s of white noise
(80 dB) was presented and co-terminated with a 2 s, 0.7 mA foot
shock. This noise-shock paring was repeated twice for a total of 3
shocks, using an interval of 30 s between shocks. Twenty-four
hours later, mice were placed back into the same chamber and
freezing was measured for 5 min. Four hours later, mice were
placed in a novel context for 3 min then re-exposed to the white
noise (cued tone response) for 3 min and freezing was analyzed.
Novel object recognition was preformed with assistance from the
University of Rochester Behavioral Science Facility Core. This test
was performed and scored as described previously [26]. Our
learning trial time was 10 minutes and the testing trial time was 5
minutes with a one hour delay between each trial. The entire first
10 min session was scored while only the first 2 min of the 2
nd test
session was scored. A recognition index (RI) for time spent with the
novel object was calculated based on the proportion of total time
spent with the novel object.
Tissue Collection
Animals were anesthetized and perfused with saline as pre-
viously described [16]. The brains were then harvested and the
hemispheres were bisected with a razor blade. The right half was
fixed in ice cold 4% paraformaldehyde (PFA) while the left half
was snap-frozen in isopentane and stored at 280uC until used for
ELISA and Western blot analysis. The fixed tissue remained
overnight in 4% PFA at 4uC and was then transferred to 30%
sucrose until equilibrated.
Immunohistochemistry (IHC)
Brains were sectioned at 30 mm on a sliding knife microtome
with a 225uC freezing stage. Sections were stored in cryoprotec-
tant at 220uC until processing. Antibody staining was visualized
using either biotinylated secondary antibodies, avidin-biotin
complex (Elite), and a 3,3-diaminobenxadine (DAB) substrate kit
(Vector Laboratories) or, immunofluorescent secondary antibodies
bound to Alexa fluorophores (Invitrogen) at a dilution of 1:500.
Primary antibodies used were mouse anti-6E10 (Covance, 1:1000),
rabbit anti-GFAP (DAKO 1:1000), rabbit anti-Iba-1 (Wako,
1:2000), rabbit anti-CD68 (AbD Serotec, 1:500), and Armenian
hamster anti-ICAM (Thermo Scientific, 1:1000). Biotinylated
secondary antibodies against their proper species (Jackson
Laboratory) were used at 1:1000. For Congo red staining, a kit
from Sigma-Aldrich was used.
Quantification of Amyloid Plaque Load and Glial
Activation
Brains sections were viewed with an Axioplan 2i light
microscope (Zeiss). For plaque area, a 5x lens was used. Multiple
images were taken of a single section to obtain pictures of the
whole cortex and hippocampus. Images were merged in Photo-
shop and subjected to threshold analysis using the max entropy
threshold algorithm in NIH ImageJ (V1.46, http://rsbweb.nih.
gov/ij/). The percent area occupied by 6E10 or Congo red of the
cortex and hippocampus was calculated and analyzed. In addition
to the percent area of 6E10, the total number and average size of
6E10 positive plaques was obtained using this threshold algorithm.
The percent area occupied by GFAP was calculated for cortex
only. Values obtained for male mice were analyzed with a one-way
ANOVA followed by Bonferroni post test comparing the different
doses. Values for female mice were analyzed with a Student’s t-
test.
Microglial activation was analyzed by capturing images at 40x
magnification. Images were taken of Congo red stained dense
plaques. The images were transferred to NIH ImageJ and the
three color channels comprising CD68, Iba-1, and Congo red
were separated and viewed individually. A 500 pixel total area
circle was placed in the center of each plaque. In total, 6 Congo-
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analyzed and averaged together for each mouse. Using the max
entropy threshold algorithm we calculated the percent area inside
the 500 pixel circle occupied by CD68, Iba1, and Congo red.
Prism v5 (Graphpad Software) was used for all statistical analyses.
A value of p , 0.05 was considered significant.
Protein Quantification
Western blot and ELISA protein samples were prepared as
previously described [16,27]. Briefly, half brains were homoge-
nized then sonicated in 1 mL of T-per (Pierce) and protease
inhibitor cocktail set I (Calbiochem). 100 mL of homogenized
sample was removed and stored at 280uC for Western blot.
Remaining samples were centrifuged at 100,000g for 60 minutes.
Supernatants (soluble fraction) were removed and the pellet was
resuspended in 150 mg/mL Guanidinium HCL pH 8.0 followed
by recentrifugation at 100,000g to generate an insoluble fraction.
Soluble and insoluble Ab isoforms were assayed using Invitrogen
ELISA kits for Ab42 and Ab40 (#KHB3544 and #KHB3841,
respectively). T-per soluble fractions were also used for TNFa
ELISA (#KMC3011). Protein concentrations for Western blot
samples were measured with a Micro BCA protein assay (Thermo
Scientific). 15 mg of protein was subjected to SDS-PAGE,
transferred to polyvinylidene difluoride, and probed with anti-
bodies specific against the following substrates: Mouse anti-
Amyloid Precursor Protein (Covance, 1:1000), Rabbit anti-b-
CTF (Sigma, 1:1000), Rabbit anti-IDE (Calbiochem 1:1000),
Rabbit anti-LRP1 (Epitomics, 1:10,000), and a-tubulin (Calbio-
chem, 1:5000). Only the male 0 cGy and 100 cGy samples were
used for Western blots.
Results
To assess the effect of iron galactic cosmic radiation on memory
and cognition two separate tests were employed prior to tissue
harvest at 9.5 mo for males and 7 mo for females. To assess
hippocampal-dependent memory, the first test used was contextual
fear conditioning (Fig. 1A). We found an overall significant
difference in freezing behavior as measured by one-way ANOVA
in the male group [F(2,32)=5.122, p=.0118] and post-hoc
analysis revealed a significant decrease in freezing behavior
between the 0 cGy and 100 cGy conditions. In female mice at 7
months of age, there was a trend towards increased freezing after
100 cGy irradiation (p=.0561) (Fig. 1A). Radiation did not have
a significant effect on freezing relative to a novel environment or
a cued tone response in either sex (Fig. 1B). The second cognitive
test used was a novel object recognition paradigm, which depends
on multiple areas of the brain. One-way ANOVA revealed
a significant change in the males [F (2,34)=11.99, p,.0001] and
post-hoc showed a decrease in exploratory time spent with the
novel object for both the 10 cGy and 100 cGy irradiated male
groups (Fig. 1C). A Student’s t-test showed significant loss of novel
object recognition in the female group exposed to 100 cGy
(p,.0001).
The radiation induced defects in learning and memory
prompted us to examine if there were any alterations of Ab
pathology. Figure 2 shows results from two different kinds of
amyloid stains. Congo red was used to stain dense fibrillar plaques
(Fig. 2A, B) and 6E10, which recognizes an epitope within amino
acid residues 1–16 of Ab, labels fibrillar and non-fibrillar Ab
(Fig. 2C, D). At 9.5 mo of age, exposure of male mice to 100 cGy
of radiation was sufficient to cause a significant increase of 38.0%
in Congo red- [F(2,33)=4.839, p=.014] (Fig. 2B) and a 53.8%
increase in 6E10- [F(2,32)=8.132, p=.0014) (Fig. 2D) labeled
plaque burden (percent area). The 7 mo-old females did not show
any significant difference in Congo red (p=.1011) or 6E10
(p=.1585). Using 6E10 labeling, male mice exposed to
56Fe
particle radiation also showed a significant increase of 300 6 56 to
447 6 147 (mean 6 SD, p=.0044) (Fig. 2E) in the average
number of plaques after 100 cGy irradiation. Additionally, there
was a trend towards larger plaque size (587 6 50 to 628 6 51
mm
2, mean 6 SD, p=.052) (Fig. 2F) in the males irradiated with
100 cGy compared to controls (0 cGy). Females did not show any
changes in plaque size or number with radiation.
To strengthen our histology data and determine whether
different forms of Ab were altered after radiation, we prepared
soluble and insoluble fractions of homogenized hemibrains and
used ELISAs specific for Ab peptides with C-terminals of 40 or 42
(Fig. 3). For the soluble fraction, there was a significant 35.9%
increase in Ab40 levels with 100 cGy radiation in male mice
compared to non-irradiated controls by one-way ANOVA
[F(2,34)=4.332 p=.0211] (Fig. 3A). Moreover, male mice showed
significant 14.8% and 10.2% increases in concentrations of Ab42
in the insoluble fraction at both 10 and 100 cGy, respectively
[F(2,36)=6.253 p=.0047] (Fig. 3D), and a trend (p=.09) toward
increased levels of insoluble Ab40 after irradiation (Fig. 3C). No
statistically significant effects were observed for Ab40 or Ab42
concentrations in samples prepared from female mice.
The increases found in the insoluble fraction (Fig. 3D) confirm
our IHC results of Ab accumulation in the males (Fig. 2). The
increase in different Ab isoforms suggests possible changes in the
production of the amyloid precursor protein (APP) or increased
cleavage of APP as measured by the b-secretase cleavage product
(b-CTF). To determine if radiation influenced either of these
processes, we measured levels of APP and b-CTF by Western blot
in male mice exposed to 100 cGy
56Fe particles. As shown in
Figures 3E and 3F, no changes in levels of these two species were
observed relative to unirradiated controls. This suggests that the
observed increases in Ab were not due to increased APP
production or processing of amyloid.
The increase in Ab observed by IHC and ELISA, but lack of
evidence for alteration of amyloid processing, directed us to
investigate other mechanisms. Due to lack of change in the female
mice we elected to focus on samples from males irradiated at
100 cGy for these analyses. Microglia are principle players in CNS
inflammation, which has been proposed to be an important driver
of amyloid deposition. In addition, they are implicated in
phagocytosis and control of Ab [28]. We sought to identify if
there was a change in the association of microglia with plaques or
alterations in their level of activation that might relate to increased
plaque accumulation following radiation (Fig. 4). CD68 is
a commonly used marker that is upregulated in activated microglia
[29] and is indicative of a phagocytic state. We did not observe any
increase in CD68 area, normalized to plaque area or total Iba-1+
area, after 100 cGy radiation (Fig. 4A, B). Similarly, there was no
effect of radiation on total Iba-1+ microglia area associated with
plaques (Fig. 4C). Figure 4D contains representative images of
CD68+/Iba-1+ microglia around plaques. General microglial
morphology based on Iba-1 staining appeared similar in control
and irradiated brain (Fig. 4E). Moreover, there was no significant
change (p=.19) in cortical area covered by GFAP (Fig. 4F). To
measure the ability of microglia to degrade Ab, we quantified one
of the key enzymes associated in that process, insulin degrading
enzyme (IDE) [30] (Fig. 4G). There was no statistical difference
between the control and irradiated mice when analyzed with
a Student’s t-test (p=.22). Lastly, we investigated the amount of
the inflammatory cytokine TNFa (Fig. 4H). We did not detect any
difference between irradiated and control levels (p=.39). Taken
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glial activation 6 months after 100 cGy radiation exposure.
Due to the importance of Ab clearance out of the brain through
the BBB [20] we next examined vascular alterations in the
irradiated animals. Sections were stained with ICAM-1, a marker
of endothelial activation (Fig. 5). ICAM-1 is also thought to be an
indirect marker of CNS damage or inflammation that we have
previously demonstrated in irradiated mouse CNS [4,31]. Relative
to control tissue, a significant increase in ICAM-1 total staining
through the cortex was observed after 100 cGy radiation as judged
by Student’s t-test (p=.0031) (Fig. 5A, B). To begin to assess
transport of Ab out of the brain, levels of low-density lipoprotein
receptor-related protein 1 (LRP1) were quantified in tissue samples
by Western blot. LRP1 is a critical protein involved in binding Ab
and trafficking it out of the brain [32] that can be modulated by
peripheral inflammatory signals [33]. Even though radiation
resulted in increased endothelial activation, we did not observe
any difference in LRP1 protein level 6 months after 100 cGy
56Fe
particle irradiation (Fig. 5C).
Discussion
Here we report that GCR caused enhanced AD plaque
pathology. To our knowledge, this is the first report of radiation
being associated with enhanced plaque pathology in an AD mouse
model. In addition to disease acceleration, we observed that low
HZE doses are able to cause cognitive impairment as measured by
contextual fear conditioning and novel object recognition in APP/
PS1 tg mice (Fig. 1). While contextual fear conditioning and, to
acertainextent,novelobjectrecognitionaredependentonanintact
hippocampus,thecuedtonefreezingresponseisthoughttomeasure
hippocampalindependentmemory[34,35].Thelackofimpairment
in tone mediated freezing demonstrates that the cognitive dysfunc-
tion we observe can be, at least in part, traced to hippocampal
mediatedmemoryprocesses.Thisisconsistentwithotherreportson
the effect of radiation impacting hippocampal dependent memory
[7,36].Becausewedidnotrunparallelstudieswithwild-typecontrol
mice, we do not know whether cognitive impairment resulted from
radiation alone or represented a synergy between radiation and
mutant AD gene expression in these mice. HZE irradiation alone
canleadtocognitivedeficitsinwild-typemice[7];however,theonly
report of deficits in contextual fear conditioning or novel object
recognitionwithC57BL/6 micerequired200or300 cGyiron[37].
Unfortunately, differences in mouse strain, timing, and radiation
beam energy limit our ability to extrapolate from these studies.
Multiple possible radiation induced effects might contribute to
cognitive dysfunction in our model. One example is a defect in
Figure 1. Effect of
56Fe particle radiation on memory and cognition using contextual fear conditioning and novel object
recognition tests. (A) Fear conditioning results quantified as percent time freezing. (B) No significant difference was found between any groups in
freezing to a novel context or a tone stimulus. (C) Novel object recognition test using the recognition index generated for time spent with the novel
object. All data is compared within the respective gender. Data was analyzed with Student’s t-test for the females and one-way ANOVA with
a Bonferroni post test for the males. Graphs show means 6 SD, n=8–14 animals per condition at each dose. **P,.01, ***P,.001.
doi:10.1371/journal.pone.0053275.g001
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radiotherapy [38] as well as exposure to
56Fe particles [5,7,39]. In
addition to neuronal proliferation defects, impaired cognition could
also result from inhibition of long-term potentiation (LTP) [40], an
effect which has been reported with
56Fe particle irradiation in the
APP23 transgenic mouse model of AD [41].
Figure 2. Immunohistochemical staining for Congo red and 6E10 increases after
56Fe particle irradiation. (A, C) Representative images
of half male brains stained for Congo red (A) or 6E10 (C) 6 months after 0 cGy or 100 cGy
56Fe particle radiation. Scale bar is 1 mm. (B, D) Quantitative
measurement of percent plaque area assessed with Congo red (B) and 6E10 (D). In addition, total number of individual 6E10 positive plaques (E) and
the average size of plaques (mm
2)( F) was determined. Each dot represents a single animal measured as percent area of the cortex and hippocampus
combined. Data was analyzed with Student’s t-test for the females and one-way ANOVA with a Bonferroni post test for the males. Data displayed as
mean 6 SD, n=8–14 animals per dose. *P,.05, **P,.01.
doi:10.1371/journal.pone.0053275.g002
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insoluble Ab40 (C) and Ab42 (D). Each dot represents one animal. Data was analyzed with Student’s t-test for the females and one-way ANOVA with
a Bonferroni post test for the males. (E, F) Male 0 cGy and 100 cGy APP (E) and b-C terminal fragment (F) protein levels were measured via Western
blot and standardized to a-tubulin. Representative images of blots are present in E’ and F’. Results were analyzed with Student’s t-test. Data displayed
as mean 6 SD, n=8–14 animals per dose. *P,.05, **P,.01.
doi:10.1371/journal.pone.0053275.g003
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accumulation as judged by two different markers. 6E10 showed an
increase in total deposited Ab levels and Congo red showed an
increase in aggregation of plaques into dense fibrils. These results
were further confirmed by ELISA data (Fig. 3). Ab plaque staining
is used to gauge progression and stage AD pathology [12]. The
increases observed in soluble Ab and insoluble plaque deposition
suggest that GCR caused more rapid progression of AD, at least
for male mice. The female group was sacrificed at an earlier age
than the male mice due to concerns related to several female mice
dying early. Given the small number that died, we do not know
whether this was related to radiation; our goal was to have a large
enough cohort for behavioral and tissue analysis. Thus the male
and female groups are not comparable. Moreover, APP/PS1
Figure 4. There is no change in glial activation after
56Fe particle irradiation. (A) CD68 area was normalized to individual plaque area to
account for differences in plaque size. 12 plaques in each mouse were analyzed and averaged together to compare male control and 100 cGy
irradiated mice. (B) CD68 was also normalized to the total Iba-1 microglia area around the plaque to account for potential changes in microglia
number. (C) Iba-1 area was standardized to plaque area. Each dot represents a single animal. (D) Visual representation of CD68/Iba-1 staining around
a plaque. Images acquired at 40x magnification, scale bar is 5 mm. (E) Representative hippocampal images taken to demonstrate Iba-1+ microglial
morphology. Images acquired at 20x magnification, scale bar is 10 mm. (F) Astrocyte activation was measured using GFAP percent area
measurements in the cortex (n=4–5 mice per dose). (G) Insulin Degrading Enzyme (IDE) protein level was measured and quantified via Western blot
analysis. IDE levels were normalized against a-tubulin as a loading control (n=7 mice per dose). Representative images are shown in G’.( H) Protein
levels of TNFa were quantified via ELISA. Data is presented as mean 6 SD. The results were analysed with Student’s t test, n=13–14 mice per dose in
A, B, C and H.
doi:10.1371/journal.pone.0053275.g004
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males [42]; therefore it is not possible to draw specific conclusions
on gender difference of
56Fe particle radiation.
The doses used in this study are comparable to those astronauts
will see on a mission to Mars [2,3], raising concerns about
a heightened chance of debilitating dementia occurring long after
the mission is over. Increased plaque progression could be due to
a variety of mechanisms. A primary mechanism of radiation injury
is DNA damage and reactive oxygen species production [38,43]
that can contribute to overall cell dysfunction. In addition,
radiation is also known to cause glial activation and inflammatory
cytokine production [4], both of which have been implicated in
neurodegenerative diseases like AD [44]. In our study, GCR
exposure could amplify the chronic inflammatory AD state and
speed up pathology. However, we did not find clear evidence of
neuroinflammation using markers previously shown to be elevated
using higher doses of gamma and HZE irradiation [4,5,45].
However, subtle inflammatory changes could be occurring that we
were not able to visualize by conventional immunohistochemical
methods. Additionally, investigators have shown there is a biphasic
pattern of inflammatory cytokines over several months after
irradiation [4,45], suggesting the possibility that significant
changes at another time point might have been missed. Indeed,
Encinas et al. observed accumulation of Iba1+ microglia in the
hippocampal subgranular zone 6 h post 100 cGy
56Fe radiation
exposure. This effect was not seen 24 h or 3 weeks after irradiation
[46]. This observation is consistent with microglial reaction to
hippocampal neural precursor cells undergoing apoptosis in
response to radiation [47], and suggests that neuroinflammation
might occur in our model at an acute time point.
Microglia have been implicated in plaque maintenance in
a number of models [28,44,48,49]. Although radiation induced
changes in microglia might result in increased plaque deposition,
we did not find alteration in several measures related to microglial
function. Moreover, we observed no increase in the Ab degrading
enzyme IDE as pathology worsens after 100 cGy irradiation
(Fig. 4F). IDE is an enzyme that is present in several CNS cell
types [30]. Importantly, it is thought that microglia can secrete it
to degrade extracellular Ab [50]. One could argue that the lack of
increased IDE is a significant finding since it would be expected
that as pathology worsens, there should be an upregulated
response. It is important to note that IDE is not the only protease
implicated in Ab degradation. Other proteases like neprilysin or
MMP9 could potentially be involved [30].
An additional hypothesis is that radiation causes vascular
defects, which impair proper clearance of Ab. Clearance through
the vasculature has been shown to be crucial [20] and alterations
by various means can result in increased pathology [33]. Radiation
Figure 5.
56Fe particle radiation causes endothelial activation. (A) Representative images of ICAM-1 staining. Pictures are at 20x magnification
and the scale bar is 10 mm. (B) ICAM-1 area was measured as percent total area in the entire cortex in 2 serial sections with the results being averaged
together. Each dot represents a single animal. (C) Protein samples were analyzed for LRP1 using Western blot. LRP1 levels were standarized against a-
tubulin as a loading control. Representative immunoblot image is present in C’. Data is presented as mean 6 SD. Results were analysed with
a Student’s t-test. n=13–14 animals per dose.
doi:10.1371/journal.pone.0053275.g005
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including increased permeability [4,31,51]. We found significant
increases in ICAM-1 staining in male mice 6 months after
exposure to 100 cGy
56Fe particles (Fig. 5). It is tempting to
speculate that radiation-induced vascular changes alter the
transport of Ab out of the brain. Even though we did not observe
any change in LRP1, which is associated with Ab removal from
the brain and known to be influenced by inflammatory stimuli
[33], there are additional transporters found at the BBB that might
have a role in Ab removal [20]. Ultimately, Ab tracer studies will
be required to definitively demonstrate impaired clearance in
irradiated mice.
In conclusion we have demonstrated that 100 cGy of
56Fe
particle radiation can cause cognitive impairment as well as
increased Ab plaque pathology in APP/PS1 mice, without clear
changes in glial activation. Additionally, the elevation of ICAM-1
expression in irradiated mice raises the possibility that vascular
changes might underlie radiation-induced amyloid accumulation.
These pathological increases are particularly concerning for
astronauts who will be exposed to GCR in upcoming deep space
missions. In this regard, one major caveat of our model is that
mice were subjected to acute exposures with a single HZE species.
It is not known how the CNS will respond to the complex and
chronic low-dose GCR environment of space. Moreover, astro-
nauts will not likely be familial AD carriers. Therefore, while many
of the pathological processes are believed to be similar, this model
does not reflect the complete human condition. However, for the
one aspect we can replicate, the accumulation of Ab, our findings
demonstrate that whole body exposure to
56Fe particle HZE
radiation enhances pathological processes associated with pro-
gression of AD.
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